Must Asset Management Inc. Biomarin Pharmaceutical Inc Transaction History

Must Asset Management Inc.

  • $36.8 Million
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$74.28 - $92.69 $503,544 - $628,345
-6,779 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$75.51 - $84.79 $326,807 - $366,971
-4,328 Reduced 38.97%
6,779 $566,000
Q4 2020

Feb 03, 2021
BUY
$72.61 - $90.2 $806,479 - $1 Million
11,107 New
11,107 $966,000

Others Institutions Holding BMRN

# of Institutions
635
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Must Asset Management Inc. Portfolio

Follow Must Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Must Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Must Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email